Sign in
4

Changes in Ownership

CytoDyn Inc. Filed Acc 0000899243-17-015331

Options or other derivatives

  • President and CEO acquired 300,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Pourhassan Nader President and CEO 2017-06-01 Grant or award · Stock Options (right to buy) +300,000 300,000 D
Loading xslF345X03/doc4.xml…